Discover the latest breakthroughs in oncology, including FDA approvals and innovative therapies reshaping cancer treatment ...

Detailed price information for Celldex Therapeutics (CLDX-Q) from The Globe and Mail including charting and trades.

Q2 2025 Pre Recorded Earnings Conference Call August 7, 2025 2:00 AM ETCompany ParticipantsKhalid Waleed Hosny ...

Verde AgriTech Ltd (TSX: 'NPK”) ('Verde” or the 'Company”) announces its financial results for the period ended June 30, 2025 ...

Verde AgriTech Ltd (TSX: "NPK") ("Verde" or the "Company") announces its financial results for the period ended June 30, 2025 ("Q2 2025"). All figures are ...

Q2 2025 Earnings Call Transcript August 6, 2025 Fortrea Holdings Inc. beats earnings expectations. Reported EPS is $0.19, ...

CARY, N.C., Aug. 8, 2025 Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology ...

Winning at both cluster and provincial levels is a testament to Tebello's hard work, dedication, and passion for research.

Strathcona Resources Ltd. ("Strathcona" or the "Company") (TSX: SCR) today reported its second quarter 2025 financial and ...

Announced strategic research collaboration with Chugai for two undisclosed molecules – – Presented preclinical data ...

NDA for icotrokinra for the treatment of adults and adolescents 12 years of age and older with moderate to severe plaque ...

Net loss (GAAP) increased by $5,600,000 to $16,600,000 for the fiscal third quarter ended June 30, 2025, reflecting a ...